NASDAQ: RVPH
Reviva Pharmaceuticals Holdings Inc Stock Ownership - Who owns Reviva Pharmaceuticals Holdings?

Insider buying vs selling

Have Reviva Pharmaceuticals Holdings Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when RVPH insiders and whales buy or sell their stock.

RVPH Shareholders

What type of owners hold Reviva Pharmaceuticals Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc2.78%3,197,581$687.48kInstitution
Laxminarayan Bhat2.16%2,484,244$534.11kInsider
Millennium Management LLC1.97%2,263,470$486.65kInstitution
Tenzing LLC1.84%2,121,750$456.18kInsider
Parag Saxena1.67%1,924,250$413.71kInsider
Rahul Nayar1.67%1,924,250$413.71kInsider
Geode Capital Management LLC0.91%1,048,954$225.53kInstitution
Glazer Capital LLC0.88%1,017,000$218.66kInsider
Jane Street Group LLC0.78%894,749$192.37kInstitution
Mizuho Securities Usa LLC 10.71%817,750$175.82kInsider

1 of 3

RVPH vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RVPH9.69%9.28%
KYNB8.77%91.23%Net BuyingNet Selling
XLO53.27%46.73%Net BuyingNet Selling
PASG4.08%95.92%Net SellingNet Selling
ENLV5.44%59.15%

Reviva Pharmaceuticals Holdings Stock Ownership FAQ

Who owns Reviva Pharmaceuticals Holdings?

Reviva Pharmaceuticals Holdings (NASDAQ: RVPH) is owned by 9.69% institutional shareholders, 9.28% Reviva Pharmaceuticals Holdings insiders, and 81.03% retail investors. Laxminarayan Bhat is the largest individual Reviva Pharmaceuticals Holdings shareholder, owning 2.48M shares representing 2.16% of the company. Laxminarayan Bhat's Reviva Pharmaceuticals Holdings shares are currently valued at $606.16k.

If you're new to stock investing, here's how to buy Reviva Pharmaceuticals Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.